Brain & Spine Clinic

29/06/2019

Wonderful

The US Food and Drug Administration has approved eculizumab for the first treatment of adult patients with the rare autoimmune disease neuromyelitis optical spectrum disorder (NMOSD).

31/05/2019

In two small case series, injections of botulinum toxin into the glabellar region -- the area between the eyebrows and above the nose -- reduced symptoms of bipolar depression and social anxiety.

18/04/2019

Erenumab and Galcanezumab are the first ever Migraine-specific treatments approved by the FDA for treatment of Migraine in Adults. They act on the main molecule involved in the mechanism of Migraine, the CGRP molecule. Both treatments are available at our clinic with excellent results so far.

27/12/2018

Share the Good news for Parkinsonians

Levodopa inhalation powder aims to fill an unmet need for roughly 40% of patients with Parkinson's who experience off periods while taking an oral regimen of carbidopa-levodopa.

01/08/2018

Worth sharing

29/04/2018

27/02/2018

Just for your knowledge ! Worth sharing

Yawning is a unique and reliable symptom in patients with migraine that may offer an opportunity for early treatment, new research suggests.

29/05/2017

Polyunsaturated fatty acids promote healthy aging of the brain by supporting integrity of structures underpinning fluid intelligence and memory.

27/04/2017

CAD guidelines call for a reduction in saturated fat consumption. With meta-analyses challenging the link between saturated fat and CAD risk, is it time to pardon this 'cardiovascular villain'?

24/04/2017

Gamma Core is now approved by the FDA for Cluster headache !

04/11/2016

03/11/2016

Very early intensive mobilization was harmful compared with usual care for stroke in terms of deaths at 14 days, especially for older patients and more severe strokes, safety results from the AVERT trial show.